Joshua Vieth
Rutgers, The State University of New Jersey
H-index: 7
North America-United States
Top articles of Joshua Vieth
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
Cancer Immunology, Immunotherapy
2023/6
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
European Journal of Medical Research
2022/7/2
Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report
Frontiers in Medicine
2022/6/15
Modulating expression of a BTB-ZF transcription factor in adipose resident NKT cells alters function and disrupts metabolism regulation.
The Journal of Immunology
2022/5/1
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
medRxiv
2022/2/3
Publisher Correction: Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
Nature cancer
2021/9
Abstract CT139: Intratumoral oncolytic virus V937 in combination with pembrolizumab (pembro) in patients (pts) with advanced melanoma: Updated results from the phase 1b CAPRA study
Cancer Research
2021/7/1
CD6 is highly expressed in fatal asthma patients and may modulate bronchomotor tone
2020/9/7
Joshua Vieth
H-Index: 4
Taylor Doherty
H-Index: 0
Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
Nature Cancer
2020/9
A phase Ib study of troriluzole (BHV-4157) in combination with nivolumab.
2020/2/10
Co-Authors
